APA

Bardet E., Bourhis J., Cals L., Fayette J., Guigay J., Hans S., Saint-Guily J. L., Lagarde F., Lallemant B., Milano G., Rolland F. & Lefebvre J. (20091021). [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]. : Bulletin du cancer.

Chicago

Bardet E, Bourhis J, Cals L, Fayette J, Guigay J, Hans S, Saint-Guily J Lacau, Lagarde F, Lallemant B, Milano G, Rolland F and Lefebvre J-L. 20091021. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]. : Bulletin du cancer.

Harvard

Bardet E., Bourhis J., Cals L., Fayette J., Guigay J., Hans S., Saint-Guily J. L., Lagarde F., Lallemant B., Milano G., Rolland F. and Lefebvre J. (20091021). [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]. : Bulletin du cancer.

MLA

Bardet E, Bourhis J, Cals L, Fayette J, Guigay J, Hans S, Saint-Guily J Lacau, Lagarde F, Lallemant B, Milano G, Rolland F and Lefebvre J-L. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]. : Bulletin du cancer. 20091021.